Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...

The presence of multinational pharma companies (MNCs) in India's drug market continues to shrink, reaching 14.5% in May 2025 ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has experienced a 60% sales increase in India between April and May.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Wall Street's major averages on Friday took home gains, with the S&P 500 reclaiming the 6,000 level for the first time since ...

The jobless rate held steady in May, but forecasts signal labor market weakness ahead, with inflation limiting Fed action.

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Bank of America Corp DE lowered its stake in shares of BNY Mellon International Equity ETF (NYSEARCA:BKIE – Free Report) by 5.9% during the fourth quarter, HoldingsChannel reports. The firm owned ...